Nanomedicine News

RSS

V-Smart Nanovesicle Platform Developer Receives Research Grant

Biotechnology firm, Lauren Sciences has declared that The Michael J. Fox Foundation for Parkinson's Research has awarded a grant to the company to further develop its innovative V-Smart nanovesicle platform technology for target-specific delivery of glial-derived naturetic factor (GDNF) systemically to the brain across the blood brain barrier for treating Parkinson's disease.

9 Feb 2012

Novel Nanoparticle Microfluidic Color Diagnostic Device for Acute Sepsis

Researchers at the Attophotonics Biosciences in Austria and the University of Applied Sciences, in Wiener Neustadt, have collaborated to develop a novel nanoparticle microfluidic color device for nanotech medical diagnostics. The lab-on-a-chip was able to detect interleukin-6 as a vital marker for acute sepsis.

8 Feb 2012

Polymersome Study Helps Advance Nanomedicine Applications

A research team at the Organic Polymer Chemistry Laboratory (CNRS/ Bordeaux 1 University/ Polytechnic Institute of Bordeaux) has succeeded in encapsulating nanovesicles inside slightly larger vesicles, paving the way for new options in terms of compartmentalized reactors, multiple encapsulation and vector administration through new delivery channels.

2 Feb 2012

Notice of Allowance for Alnylam’s Patent Covering Second Generation LNP Platform

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has declared the issuance of a notice of allowance by the United States Patent and Trademark Office (USPTO) for the patent application number 12/813,448 that covers the company’s in-house second generation lipid nanoparticle platform and the MC3 lipid.

1 Feb 2012

Report Analyzes Role of Nanotechnology in Drug Delivery

Research and Markets has declared the inclusion of a market report titled ‘Nanotechnology in Drug Delivery 2011-2021’ to its offering.

From Research and Markets 31 Jan 2012

Researchers Develop Novel Protein Nanoclusters to Help Advance Drug Delivery

A research team comprising Keith P. Johnston, Thomas M. Truskett and Jennifer Maynard from the Cockrell School of Engineering at The University of Texas at Austin has developed a novel protein formulation strategy to develop advanced drug delivery systems for treating arthritis, cancer and infectious diseases easily, efficiently and safely.

31 Jan 2012